Cargando…
The LPA-CDK5-tau pathway mediates neuronal injury in an in vitro model of ischemia-reperfusion insult
Lysophosphatidic acid (LPA) is a common glycerol phospholipid and an important extracellular signaling molecule. LPA binds to its receptors and mediates a variety of biological effects, including the pathophysiological process underlying ischemic brain damage and traumatic brain injury. However, the...
Autores principales: | Wang, Yaya, Zhang, Jie, Huang, Liqin, Mo, Yanhong, Wang, Changyu, Li, Yiyi, Zhang, Yangyang, Zhang, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059403/ https://www.ncbi.nlm.nih.gov/pubmed/35501719 http://dx.doi.org/10.1186/s12883-022-02694-2 |
Ejemplares similares
-
Lysophosphatidic Acid Induces Apoptosis of PC12 Cells Through LPA1 Receptor/LPA2 Receptor/MAPK Signaling Pathway
por: Zhang, Jie, et al.
Publicado: (2020) -
Evaluation of Antioxidant and Cerebroprotective Effect of Medicago sativa Linn. against Ischemia and Reperfusion Insult
por: Bora, Kundan Singh, et al.
Publicado: (2011) -
Hippocampal Sector–Specific Metabolic Profiles Reflect Endogenous Strategy for Ischemia-Reperfusion Insult Resistance
por: Krupska, Olga, et al.
Publicado: (2020) -
Regulation of T Cell Motility In Vitro and In Vivo by LPA and LPA2
por: Knowlden, Sara A., et al.
Publicado: (2014) -
LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study
por: Yu, Xuechen, et al.
Publicado: (2016)